From bloodless surgery to patient blood management

Mount Sinai Journal of Medicine

Volumn 79, Issue 1, 2012, Pages 56-65

  Shander, Aryeh ^a,b   Javidroozi, Mazyar ^a   Perelman, Seth ^a   Puzio, Thomas ^a   Lobel, Gregg ^a  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

blood conservation; bloodless; outcomes; patient blood management; transfusion

Indexed keywords

ANTIANEMIC AGENT; FERRIC HYDROXIDE SUCROSE; FERROUS GLUCONATE; HEMOSTATIC AGENT; IRON;

ANAMNESIS; ANAPHYLAXIS; ANEMIA; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SPARING PERFUSION; BLOODLESS CARE; HEMATOPOIESIS; HUMAN; PATIENT BLOOD MANAGEMENT; PATIENT CARE; PHYSICAL EXAMINATION; TREATMENT INDICATION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HEMOSTATIC TECHNIQUES; HUMANS; PRACTICE GUIDELINES AS TOPIC; SURGICAL PROCEDURES, OPERATIVE;

EID: 84855818684     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.21290     Document Type: Article

References (71)

1. Perkins HA, Busch MP., Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010; 50: 2080-2099.
2. Shander A., Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 2004; 41 (1suppl 1): 117-124. (Pubitemid 38182727)
3. Shander A, Goodnough LT., Why an alternative to blood transfusion? Crit Care Clin 2009; 25: 261-277.
4. Shander A, Hofmann A, Ozawa S, et al,. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-765.
5. Greinacher A, Fendrich K, Brzenska R, et al,. Implications of demographics on future blood supply: a population-based cross-sectional study. Transfusion 2011; 51: 702-709.
6. Toner RW, Pizzi L, Leas B, et al,. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy 2011; 9: 29-37.
7. Drackley A, Newbold KB, Paez A, et al,. Forecasting Ontario's blood supply and demand. Transfusion 2011; doi:10.1111/j.1537-2995.2011.03280.x.
8. Goodnough LT, Shander A, Spence R., Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003; 43: 668-676. (Pubitemid 36506366)
9. Watchtower Bible and Tract Society. Jehovah's Witnesses and the question of blood. Brooklyn, NY: Watchtower Bible and Tract Society; 1977.
10. Carson JL, Noveck H, Berlin JA, et al,. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42: 812-818.
11. Martyn V, Farmer SL, Wren MN, et al,. The theory and practice of bloodless surgery. Transfus Apher Sci 2002; 27: 29-43. (Pubitemid 34663867)
12. Nagarsheth NP, Shander A, Malovany R, et al,. Bloodless surgery in a Jehovah's Witness patient with a 12.7-kg uterine leiomyosarcoma. J Surg Educ 2007; 64: 212-219. (Pubitemid 47233306)
13. Emmert MY, Salzberg SP, Theusinger OM, et al,. How good patient blood management leads to excellent outcomes in Jehovah's Witness patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 2011; 12: 183-188.
14. Gombotz H, Rehak PH, Shander A, et al,. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468-1480. (Pubitemid 47101072)
15. Shander A, Goodnough LT., Blood transfusion as a quality indicator in cardiac surgery. JAMA 2010; 304: 1610-1611.
16. Gammon HM, Waters JH, Watt A, et al,. Developing performance measures for patient blood management. Transfusion 2011; 51: 2500-2509.
17. Shander A, Moskowitz DM, Javidroozi M., Blood conservation in practice: an overview. Br J Hosp Med (Lond) 2009; 70: 16-21.
18. Thomson A, Farmer S, Hofmann A, et al,. Patient blood management-a new paradigm for transfusion medicine? ISBT Science Series 2009; 4: 423-435.
19. Isbister JP, Shander A, Spahn DR, et al,. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 2011; 25: 89-101.
20. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988; 260: 2700-2703.
21. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208.
22. Carson JL, Hill S, Carless P, et al,. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002; 16: 187-199. (Pubitemid 34686541)
23. Napolitano LM, Kurek S, Luchette FA, et al,. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37: 3124-3157.
24. Shander A, Fink A, Javidroozi M, et al,. Appropriateness of allogeneic red blood cell transfusion: the International Consensus Conference on Transfusion Outcomes. Transfus Med Rev 2011; 25: 232-246.
25. Madjdpour C, Spahn DR., Allogeneic red blood cell transfusion: physiology of oxygen transport. Best Pract Res Clin Anaesthesiol 2007; 21: 163-171. (Pubitemid 46888183)
26. Goodnough LT, Shander A., Blood management. Arch Pathol Lab Med 2007; 131: 695-701. (Pubitemid 46726131)
27. Ferraris VA, Ferraris SP, Saha SP, et al,. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83 (5 suppl): S27-S86. (Pubitemid 46621124)
28. Teng TH, Finn J, Hung J., Mild anaemia is associated with increased all-cause mortality in heart failure. Heart Lung Circ 2010; 19: 31-37.
29. Von Haehling S, Schefold JC, Hodoscek LM, et al,. Anaemia is an independent predictor of death in patients hospitalized for acute heart failure. Clin Res Cardiol 2010; 99: 107-113.
30. Goodnough LT, Maniatis A, Earnshaw P, et al,. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
31. Shander A, Goodnough LT., Objectives and limitations of bloodless medical care. Curr Opin Hematol 2006; 13: 462-470. (Pubitemid 44607449)
32. Bennett CL, Silver SM, Djulbegovic B, et al,. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008; 299: 914-924. (Pubitemid 351397066)
33. Auerbach M, Silberstein PT, Webb RT, et al,. Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. Am J Hematol 2010; 85: 655-663.
34. Khalafallah A, Dennis A, Bates J, et al,. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010; 268: 286-295.
35. Macdougall IC., Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous? Curr Med Res Opin 2010; 26: 473-482.
36. Silverstein SB, Rodgers GM., Parenteral iron therapy options. Am J Hematol 2004; 76: 74-78. (Pubitemid 38579543)
37. Shander A, Spence RK, Auerbach M., Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents? Transfusion 2010; 50: 719-732.
38. Auerbach M, Ballard H., Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program 2010; 2010: 338-347.
39. Martin K, Keller E, Gertler R, et al,. Efficiency and safety of preoperative autologous blood donation in cardiac surgery: a matched-pair analysis in 432 patients. Eur J Cardiothorac Surg 2010; 37: 1396-1401.
40. Van de Watering L., Red cell storage and prognosis. Vox Sang 2011; 100: 36-45.
41. MacIvor D, Nelson J, Triulzi D., Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion 2009; 49: 1431-1434.
42. Billote DB, Glisson SN, Green D, et al,. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002; 84A: 1299-1304. (Pubitemid 35407572)
43. Savoia HF, Metz J, Maxwell EL, et al,. Utilization of preoperative autologous blood donation in elective surgery. ANZ J Surg 2002; 72: 557-560. (Pubitemid 35001915)
44. Choi WS, Samman N., Risks and benefits of deliberate hypotension in anaesthesia: a systematic review. Int J Oral Maxillofac Surg 2008; 37: 687-703.
45. Achneck HE, Sileshi B, Jamiolkowski RM, et al,. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251: 217-228.
46. Henry DA, Carless PA, Moxey AJ, et al,. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007; 4: CD001886.
47. Raghunathan K, Connelly NR, Kanter GJ., epsilon-Aminocaproic acid and clinical value in cardiac anesthesia. J Cardiothorac Vasc Anesth 2011; 25: 16-19.
48. Williams-Johnson JA, McDonald AH, Strachan GG, et al,. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. West Indian Med J 2010; 59: 612-624.
49. Lin Y, Stanworth S, Birchall J, et al,. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2011; 2: CD005011.
50. Levi M, Levy JH, Andersen HF, et al,. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791-1800.
51. Rajagopalan S, Mascha E, Na J, et al,. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 2008; 108: 71-77.
52. Wang G, Bainbridge D, Martin J, et al,. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109: 320-330.
53. Carless PA, Henry DA, Moxey AJ, et al,. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; 4: CD001888.
54. Esper SA, Waters JH., Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 2011; 9: 139-147.
55. Waters JH., Indications and contraindications of cell salvage. Transfusion 2004; 44 (12 suppl): 40S-44S. (Pubitemid 39636418)
56. Catling SJ, Freites O, Krishnan S, et al,. Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre. Int J Obstet Anesth 2002; 11: 128-134. (Pubitemid 34563730)
57. King M, Wrench I, Galimberti A, et al,. Introduction of cell salvage to a large obstetric unit: the first six months. Int J Obstet Anesth 2009; 18: 111-117.
58. Nagarsheth NP, Sharma T, Shander A, et al,. Blood salvage use in gynecologic oncology. Transfusion 2009; 49: 2048-2053.
59. Nieder AM, Manoharan M, Yang Y, et al,. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007; 69: 881-884. (Pubitemid 46670237)
60. Gray CL, Amling CL, Polston GR, et al,. Intraoperative cell salvage in radical retropubic prostatectomy. Urology 2001; 58: 740-745.
61. Ashworth A, Klein AA., Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010; 105: 401-416.
62. Catling S, Williams S, Freites O, et al,. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008; 63: 1332-1338.
63. Jarnagin WR, Gonen M, Maithel SK, et al,. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg 2008; 248: 360-369.
64. Bennett J, Haynes S, Torella F, et al,. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion 2006; 46: 1097-1103. (Pubitemid 44139482)
65. Fischer M, Matsuo K, Gonen M, et al,. Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. Ann Surg 2010; 252: 952-958.
66. Billote DB, Abdoue AG, Wixson RL., Comparison of acute normovolemic hemodilution and preoperative autologous blood donation in clinical practice. J Clin Anesth 2000; 12: 31-35. (Pubitemid 30204613)
67. Weiskopf RB., Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 2001; 94: 439-446. (Pubitemid 32198451)
68. Zisman E, Eden A, Shenderey A, et al,. The effect of acute autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass. Eur J Anaesthesiol 2009; 26: 868-873.
69. Wallis JP, Wells AW, Whitehead S, et al,. Recovery from post-operative anaemia. Transfus Med 2005; 15: 413-418. (Pubitemid 43942849)
70. Muñoz M, Breymann C, García-Erce JA, et al,. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94: 172-183. (Pubitemid 351379653)
71. Moskowitz DM, McCullough JN, Shander A, et al,. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg 2010; 90: 451-458.